British-Swedish pharmaceutical company AstroZeneca’s corona vaccine is not out of the question:
The Netherlands has suspended vaccination with the manufacturer’s product. First, the Ministry of Health on Friday evening decided not to vaccinate people under the age of 60 with the AstraZeneca product.
Severe side effects
The stimuli caused severe side effects in women. On Saturday, after consultation with the ministry, health officials decided to discontinue all AstraZeneca vaccines to prevent waste. More than 700 people over the age of 60 will be vaccinated with AstraZeneca over the next few days. These appointments were suspended because they could not guarantee that a few people at each vaccination center could use the entire vaccine from one ampoule. The vaccine ban is due to apply until April 7.
Five thrombosis reports in women between the ages of 25 and 65 who have been vaccinated are the reason for temporary vaccination discontinuation. One died. Officials are still investigating whether there is a link to the vaccine. So far, about 400,000 people in the Netherlands have been vaccinated with the AstraZeneca product.
In the UK, the pharmaceutical company says there have been seven deaths from rare blood clots after more than 18 million vaccinations with AstraZeneca. However, it is unclear whether these side effects of the vaccine occurred in a timely manner or by accident, UK company president June Rain told the BBC. “The benefits of preventing Govt-19 infection and its complications outweigh any risks, and everyone should be vaccinated if invited.”
Earlier, the agency reported 30 rare blood clots in 18.1 million Astrogenogen vaccines (as of March 24). 22 cases of cerebral nerve thrombosis and eight types of thrombosis have been reported. However, here too, the connection is not clear.
In Germany, federal and state health ministers on Tuesday decided that the AstraZeneca product should generally only be injected into people over the age of 60 – unless the youngster wants it at their own risk after clarifying with a doctor. In Germany, 31 suspicions of cerebral nerve thrombosis were reported earlier in the week after the AstraZeneca vaccine, as recently announced by Paul Earlich. So far, about three million people have received the initial dose of the drug. This means that in Germany, based on the one million people vaccinated, suspicion of cerebral nerve thrombosis was more frequent than in Great Britain. One can only guess the reasons for this.
In Austria, the National Vaccine Committee on Wednesday recommended continuing the vaccination program with AstraZeneca. From next Tuesday, the European Pharmaceutical Association (EMA) Security Committee will deal with the matter, among other things.
In total, more than 31 million people in the UK have received their primary vaccine, and more than half of them are with AstraZeneca. Since then the epidemic situation in the country has improved significantly, with seven cases lasting 55 cases per 100,000 population recently. The number of new daily deaths has also dropped dramatically.
“Coffee trailblazer. Social media ninja. Unapologetic web guru. Friendly music fan. Alcohol fanatic.”